Difference between revisions of "LncRNAWiki:T"
(Created page with "{|class="wikitable sortable" style="width:90%;text-align:center" |- !Name !Transcript ID !Alias !Description |- |''TARID'' |ENST00000607033.1 |N/A |TCF21 antisense RNA ind...") |
|||
Line 1: | Line 1: | ||
+ | <div style="padding:0.2em 0.5em;text-align:right;font-size:125%;font-weight:bold;color:#2d2d2d;"> | ||
+ | Jump to section in alphabetical order : [[LncRNAWiki:A|'''A''']] [[LncRNAWiki:B|'''B''']] [[LncRNAWiki:C|'''C''']] [[LncRNAWiki:D|'''D''']] [[LncRNAWiki:E|'''E''']] [[LncRNAWiki:F|'''F''']] [[LncRNAWiki:G|'''G''']] [[LncRNAWiki:H|'''H''']] [[LncRNAWiki:I|'''I''']] [[LncRNAWiki:J|'''J''']] [[LncRNAWiki:K|'''K''']] [[LncRNAWiki:L|'''L''']] [[LncRNAWiki:M|'''M''']] [[LncRNAWiki:N|'''N''']] [[LncRNAWiki:O|'''O''']] [[LncRNAWiki:P|'''P''']] [[LncRNAWiki:R|'''R''']] [[LncRNAWiki:S|'''S''']] [[LncRNAWiki:T|'''T''']] [[LncRNAWiki:U|'''U''']] [[LncRNAWiki:V|'''V''']] [[LncRNAWiki:W|'''W''']] [[LncRNAWiki:X|'''X''']] [[LncRNAWiki:Y|'''Y''']] [[LncRNAWiki:Z|'''Z''']] [[LncRNAWiki:Featured|'''BACK''']] | ||
+ | </div> | ||
{|class="wikitable sortable" style="width:90%;text-align:center" | {|class="wikitable sortable" style="width:90%;text-align:center" | ||
|- | |- | ||
Line 5: | Line 8: | ||
!Alias | !Alias | ||
!Description | !Description | ||
+ | !Disease | ||
|- | |- | ||
|''TARID'' | |''TARID'' | ||
Line 10: | Line 14: | ||
|N/A | |N/A | ||
|TCF21 antisense RNA inducing promoter demethylation | |TCF21 antisense RNA inducing promoter demethylation | ||
+ | |_ | ||
|- | |- | ||
|''TCL6'' | |''TCL6'' | ||
|[[TCL6]] | |[[TCL6]] | ||
− | |TCL6e1, TNG2, TNG1 | + | |"TCL6e1, TNG2, TNG1" |
|T-cell leukemia/lymphoma 6 (non-protein coding) | |T-cell leukemia/lymphoma 6 (non-protein coding) | ||
+ | |leukemia, lymphoma | ||
|- | |- | ||
|''TDRG1'' | |''TDRG1'' | ||
|[[NONHSAT112472]] | |[[NONHSAT112472]] | ||
− | |LINC00532, lincRNA-NRN/A024015 | + | |"LINC00532, lincRNA-NRN/A024015" |
|testis development related 1 (non-protein coding) | |testis development related 1 (non-protein coding) | ||
+ | |testicular cancer | ||
|- | |- | ||
|''TEA-ncRNAs'' | |''TEA-ncRNAs'' | ||
Line 25: | Line 32: | ||
|ENSG00000251002 | |ENSG00000251002 | ||
|T early alpha | |T early alpha | ||
+ | |_ | ||
|- | |- | ||
|''TEX41'' | |''TEX41'' | ||
|[[TEX41]] | |[[TEX41]] | ||
− | |DKFZp686O1327, LINC00953 | + | |"DKFZp686O1327, LINC00953" |
|testis expressed 41 (non-protein coding) | |testis expressed 41 (non-protein coding) | ||
+ | |_ | ||
|- | |- | ||
|''TGFB2-OT1'' | |''TGFB2-OT1'' | ||
Line 35: | Line 44: | ||
|FLJ11812 | |FLJ11812 | ||
|TGFB2 overlapping transcript 1 | |TGFB2 overlapping transcript 1 | ||
+ | |_ | ||
|- | |- | ||
|''TH2LCRR'' | |''TH2LCRR'' | ||
Line 40: | Line 50: | ||
|TH2-LCR | |TH2-LCR | ||
|T helper type 2 locus control region associated RNA | |T helper type 2 locus control region associated RNA | ||
+ | |_ | ||
|- | |- | ||
|''THRIL'' | |''THRIL'' | ||
|[[Lnc-DHX37-1:1]] | |[[Lnc-DHX37-1:1]] | ||
− | |Linc1992, TCONSN/A00020260, BRI3BP-AS1 | + | |"Linc1992, TCONSN/A00020260, BRI3BP-AS1" |
|TNF and HNRNPL related immunoregulatory long non-coding RNA | |TNF and HNRNPL related immunoregulatory long non-coding RNA | ||
+ | |Kawasaki disease | ||
|- | |- | ||
|''TINCR'' | |''TINCR'' | ||
|[[ENST00000448587.1]] | |[[ENST00000448587.1]] | ||
− | |FLJ90734, NCRNA00036, LINC00036, onco-lncRNA-16 | + | |"FLJ90734, NCRNA00036, LINC00036, onco-lncRNA-16" |
|tissue differentiation-inducing non-protein coding RNA | |tissue differentiation-inducing non-protein coding RNA | ||
+ | |squamous cell carcinoma, gastric cancer | ||
|- | |- | ||
|''TLX1NB'' | |''TLX1NB'' | ||
|[[TLX1NB]] | |[[TLX1NB]] | ||
− | |TD1, TDI, APT-B7 | + | |"TD1, TDI, APT-B7" |
|TLX1 neighbor | |TLX1 neighbor | ||
+ | |_ | ||
|- | |- | ||
|''TMEM161B-AS1'' | |''TMEM161B-AS1'' | ||
− | |[[lnc-RASA1-3:23]],[[lnc-RASA1-3:25]] | + | |[[lnc-RASA1-3:23]], |
− | |AK082072,linc-POLR3G-8, ENSG00000247828 | + | [[lnc-RASA1-3:25]] |
+ | |"AK082072,linc-POLR3G-8, ENSG00000247828" | ||
|TMEM161B antisense RNA 1 | |TMEM161B antisense RNA 1 | ||
+ | |_ | ||
|- | |- | ||
|''TMEM92-AS1'' | |''TMEM92-AS1'' | ||
|[[TMEM92-AS1]] | |[[TMEM92-AS1]] | ||
− | |RP11-893F2.9, lncRNA-508851, TCONSN/A00025237 | + | |"RP11-893F2.9, lncRNA-508851, TCONSN/A00025237" |
|TMEM92 antisense RNA 1 | |TMEM92 antisense RNA 1 | ||
+ | |_ | ||
|- | |- | ||
|''TMEM9B-AS1'' | |''TMEM9B-AS1'' | ||
Line 70: | Line 87: | ||
|N/A | |N/A | ||
|TMEM9B antisense RNA 1 | |TMEM9B antisense RNA 1 | ||
+ | |_ | ||
|- | |- | ||
|''TncRNA'' | |''TncRNA'' | ||
Line 75: | Line 93: | ||
|TSU | |TSU | ||
|TncRNA: trophoblast noncoding RNA; TSU: trophoblast STAT utron (untranslated region of an mRNA). | |TncRNA: trophoblast noncoding RNA; TSU: trophoblast STAT utron (untranslated region of an mRNA). | ||
+ | |_ | ||
|- | |- | ||
|''TOLLIP-AS1'' | |''TOLLIP-AS1'' | ||
Line 80: | Line 99: | ||
|N/A | |N/A | ||
|TOLLIP antisense RNA 1 (head to head) | |TOLLIP antisense RNA 1 (head to head) | ||
+ | |_ | ||
|- | |- | ||
|''TP53COR1'' | |''TP53COR1'' | ||
|[[TP53COR1]] | |[[TP53COR1]] | ||
− | |linc-p21, lincRNA-p21, Trp53cor1 | + | |"linc-p21, lincRNA-p21, Trp53cor1" |
|tumor protein p53 pathway corepressor 1 (non-protein coding) | |tumor protein p53 pathway corepressor 1 (non-protein coding) | ||
+ | |_ | ||
|- | |- | ||
|''TP53TG1'' | |''TP53TG1'' | ||
|[[TP53TG1]] | |[[TP53TG1]] | ||
− | |HN/ARG012D21.9, LINC00096 | + | |"HN/ARG012D21.9, LINC00096" |
|TP53 target 1 (non-protein coding) | |TP53 target 1 (non-protein coding) | ||
+ | |_ | ||
|- | |- | ||
|''TP73-AS1'' | |''TP73-AS1'' | ||
Line 95: | Line 117: | ||
|PDAM | |PDAM | ||
|TP73 antisense RNA 1 | |TP73 antisense RNA 1 | ||
+ | |esophageal squamous cell carcinoma. | ||
|- | |- | ||
|''TRERNA1'' | |''TRERNA1'' | ||
|[[TRERNA1]] | |[[TRERNA1]] | ||
− | |ncRNA-a7, treRNA | + | |"ncRNA-a7, treRNA" |
|translation regulatory long non-coding RNA 1 | |translation regulatory long non-coding RNA 1 | ||
+ | |_ | ||
|- | |- | ||
|''TRPM2-AS'' | |''TRPM2-AS'' | ||
Line 105: | Line 129: | ||
|TRPM2-AS1 | |TRPM2-AS1 | ||
|TRPM2 antisense RNA | |TRPM2 antisense RNA | ||
+ | |cancer | ||
|- | |- | ||
|''TSIX'' | |''TSIX'' | ||
|[[TSIX]] | |[[TSIX]] | ||
− | |NCRNA00013, XIST-AS1, LINC00013 | + | |"NCRNA00013, XIST-AS1, LINC00013" |
− | |TSIX transcript, XIST antisense RNA | + | |"TSIX transcript, XIST antisense RNA" |
+ | |_ | ||
|- | |- | ||
|''TSPEAR-AS2'' | |''TSPEAR-AS2'' | ||
Line 115: | Line 141: | ||
|N/A | |N/A | ||
|TSPEAR antisense RNA 2 | |TSPEAR antisense RNA 2 | ||
+ | |_ | ||
|- | |- | ||
|''TTC28-AS1'' | |''TTC28-AS1'' | ||
Line 120: | Line 147: | ||
|KIAA1648 | |KIAA1648 | ||
|TTC28 antisense RNA 1 | |TTC28 antisense RNA 1 | ||
+ | |_ | ||
|- | |- | ||
|''TTTY15'' | |''TTTY15'' | ||
|[[TTTY15]] | |[[TTTY15]] | ||
− | |DKFZP434I143, NCRNA00138 | + | |"DKFZP434I143, NCRNA00138" |
− | |testis-specific transcript, Y-linked 15 (non-protein coding) | + | |"testis-specific transcript, Y-linked 15 (non-protein coding)" |
+ | |prostate cancer sample | ||
|- | |- | ||
|''TTTY17A'' | |''TTTY17A'' | ||
|[[TTTY17A]] | |[[TTTY17A]] | ||
|NCRNA00140 | |NCRNA00140 | ||
− | |testis-specific transcript, Y-linked 17A (non-protein coding) | + | |"testis-specific transcript, Y-linked 17A (non-protein coding)" |
+ | |_ | ||
|- | |- | ||
|''TTTY3'' | |''TTTY3'' | ||
|[[TTTY3]] | |[[TTTY3]] | ||
− | |TTY3, TTTY3A, LINC00121 | + | |"TTY3, TTTY3A, LINC00121" |
− | |testis-specific transcript, Y-linked 3 (non-protein coding) | + | |"testis-specific transcript, Y-linked 3 (non-protein coding)" |
+ | |_ | ||
|- | |- | ||
|''TTTY4'' | |''TTTY4'' | ||
|[[TTTY4]] | |[[TTTY4]] | ||
− | |TTY4, TTTY4A, LINC00123 | + | |"TTY4, TTTY4A, LINC00123" |
− | |testis-specific transcript, Y-linked 4 (non-protein coding) | + | |"testis-specific transcript, Y-linked 4 (non-protein coding)" |
+ | |_ | ||
|- | |- | ||
|''TTTY5'' | |''TTTY5'' | ||
|[[TTTY5]] | |[[TTTY5]] | ||
− | |TTY5, LINC00126 | + | |"TTY5, LINC00126" |
− | |testis-specific transcript, Y-linked 5 (non-protein coding) | + | |"testis-specific transcript, Y-linked 5 (non-protein coding)" |
+ | |_ | ||
|- | |- | ||
|''TTTY6'' | |''TTTY6'' | ||
|[[TTTY6]] | |[[TTTY6]] | ||
− | |TTY6, TTTY6A, LINC00127 | + | |"TTY6, TTTY6A, LINC00127" |
− | |testis-specific transcript, Y-linked 6 (non-protein coding) | + | |"testis-specific transcript, Y-linked 6 (non-protein coding)" |
+ | |_ | ||
|- | |- | ||
|''TTTY9B'' | |''TTTY9B'' | ||
|[[TTTY9B]] | |[[TTTY9B]] | ||
|NCRNA00132 | |NCRNA00132 | ||
− | |testis-specific transcript, Y-linked 9B (non-protein coding) | + | |"testis-specific transcript, Y-linked 9B (non-protein coding)" |
+ | |_ | ||
|- | |- | ||
|''TUG1'' | |''TUG1'' | ||
|[[NONHSAT084827]] | |[[NONHSAT084827]] | ||
|ENSG00000253352 | |ENSG00000253352 | ||
− | |taurine up-regulated gene 1 | + | |taurine up-regulated gene 1 |
+ | |B-cell neoplasms, bladder cancer, Huntington's disease, non-small cell lung cancer | ||
|- | |- | ||
|''TUNAR'' | |''TUNAR'' | ||
|[[TUNAR]] | |[[TUNAR]] | ||
− | |TUNA, HI-LNC78 | + | |"TUNA, HI-LNC78" |
|TCL1 upstream neural differentiation-associated RNA | |TCL1 upstream neural differentiation-associated RNA | ||
+ | |type 2 diabetes | ||
|- | |- | ||
|''TUSC7'' | |''TUSC7'' | ||
|[[NONHSAT091315]] | |[[NONHSAT091315]] | ||
− | |LINC00902, LOC285194, ENSG00000243197 | + | |"LINC00902, LOC285194, ENSG00000243197" |
|tumor suppressor candidate 7 (non-protein coding) | |tumor suppressor candidate 7 (non-protein coding) | ||
+ | |colorectal cancer | ||
|- | |- | ||
|''TUSC8'' | |''TUSC8'' | ||
Line 175: | Line 213: | ||
|XLOCN/A010588 | |XLOCN/A010588 | ||
|tumor suppressor candidate 8 (non-protein coding) | |tumor suppressor candidate 8 (non-protein coding) | ||
+ | |cervical cancer | ||
+ | |- | ||
|} | |} |
Revision as of 12:07, 30 June 2016
Name | Transcript ID | Alias | Description | Disease |
---|---|---|---|---|
TARID | ENST00000607033.1 | N/A | TCF21 antisense RNA inducing promoter demethylation | _ |
TCL6 | TCL6 | "TCL6e1, TNG2, TNG1" | T-cell leukemia/lymphoma 6 (non-protein coding) | leukemia, lymphoma |
TDRG1 | NONHSAT112472 | "LINC00532, lincRNA-NRN/A024015" | testis development related 1 (non-protein coding) | testicular cancer |
TEA-ncRNAs | NONHSAT035776 | ENSG00000251002 | T early alpha | _ |
TEX41 | TEX41 | "DKFZp686O1327, LINC00953" | testis expressed 41 (non-protein coding) | _ |
TGFB2-OT1 | TGFB2-OT1 | FLJ11812 | TGFB2 overlapping transcript 1 | _ |
TH2LCRR | TH2LCRR | TH2-LCR | T helper type 2 locus control region associated RNA | _ |
THRIL | Lnc-DHX37-1:1 | "Linc1992, TCONSN/A00020260, BRI3BP-AS1" | TNF and HNRNPL related immunoregulatory long non-coding RNA | Kawasaki disease |
TINCR | ENST00000448587.1 | "FLJ90734, NCRNA00036, LINC00036, onco-lncRNA-16" | tissue differentiation-inducing non-protein coding RNA | squamous cell carcinoma, gastric cancer |
TLX1NB | TLX1NB | "TD1, TDI, APT-B7" | TLX1 neighbor | _ |
TMEM161B-AS1 | lnc-RASA1-3:23, | "AK082072,linc-POLR3G-8, ENSG00000247828" | TMEM161B antisense RNA 1 | _ |
TMEM92-AS1 | TMEM92-AS1 | "RP11-893F2.9, lncRNA-508851, TCONSN/A00025237" | TMEM92 antisense RNA 1 | _ |
TMEM9B-AS1 | TMEM9B-AS1 | N/A | TMEM9B antisense RNA 1 | _ |
TncRNA | NONHSAT022116 | TSU | TncRNA: trophoblast noncoding RNA; TSU: trophoblast STAT utron (untranslated region of an mRNA). | _ |
TOLLIP-AS1 | TOLLIP-AS1 | N/A | TOLLIP antisense RNA 1 (head to head) | _ |
TP53COR1 | TP53COR1 | "linc-p21, lincRNA-p21, Trp53cor1" | tumor protein p53 pathway corepressor 1 (non-protein coding) | _ |
TP53TG1 | TP53TG1 | "HN/ARG012D21.9, LINC00096" | TP53 target 1 (non-protein coding) | _ |
TP73-AS1 | TP73-AS1 | PDAM | TP73 antisense RNA 1 | esophageal squamous cell carcinoma. |
TRERNA1 | TRERNA1 | "ncRNA-a7, treRNA" | translation regulatory long non-coding RNA 1 | _ |
TRPM2-AS | TRPM2-AS | TRPM2-AS1 | TRPM2 antisense RNA | cancer |
TSIX | TSIX | "NCRNA00013, XIST-AS1, LINC00013" | "TSIX transcript, XIST antisense RNA" | _ |
TSPEAR-AS2 | TSPEAR-AS2 | N/A | TSPEAR antisense RNA 2 | _ |
TTC28-AS1 | TTC28-AS1 | KIAA1648 | TTC28 antisense RNA 1 | _ |
TTTY15 | TTTY15 | "DKFZP434I143, NCRNA00138" | "testis-specific transcript, Y-linked 15 (non-protein coding)" | prostate cancer sample |
TTTY17A | TTTY17A | NCRNA00140 | "testis-specific transcript, Y-linked 17A (non-protein coding)" | _ |
TTTY3 | TTTY3 | "TTY3, TTTY3A, LINC00121" | "testis-specific transcript, Y-linked 3 (non-protein coding)" | _ |
TTTY4 | TTTY4 | "TTY4, TTTY4A, LINC00123" | "testis-specific transcript, Y-linked 4 (non-protein coding)" | _ |
TTTY5 | TTTY5 | "TTY5, LINC00126" | "testis-specific transcript, Y-linked 5 (non-protein coding)" | _ |
TTTY6 | TTTY6 | "TTY6, TTTY6A, LINC00127" | "testis-specific transcript, Y-linked 6 (non-protein coding)" | _ |
TTTY9B | TTTY9B | NCRNA00132 | "testis-specific transcript, Y-linked 9B (non-protein coding)" | _ |
TUG1 | NONHSAT084827 | ENSG00000253352 | taurine up-regulated gene 1 | B-cell neoplasms, bladder cancer, Huntington's disease, non-small cell lung cancer |
TUNAR | TUNAR | "TUNA, HI-LNC78" | TCL1 upstream neural differentiation-associated RNA | type 2 diabetes |
TUSC7 | NONHSAT091315 | "LINC00902, LOC285194, ENSG00000243197" | tumor suppressor candidate 7 (non-protein coding) | colorectal cancer |
TUSC8 | TUSC8 | XLOCN/A010588 | tumor suppressor candidate 8 (non-protein coding) | cervical cancer |